Atox Bio
Signal active
Organization
Contact Information
Overview
Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.It focuses on novel modulators of the immune response that target key multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases as well as ischemia/reperfusion injuries.
The company was founded in 2003 and headquartered in HaMerkaz, Israel.
About
Industries
Biotechnology, Therapeutics, Clinical Trials
Founded
2003
Employees
1-10
Headquarters locations
Asia
Social
N/A
Profile Resume
Atox Bio headquartered in Asia, operates in the Biotechnology, Therapeutics, Clinical Trials sector. The company focuses on Biotechnology and has secured $2.8B in funding across 48 round(s). With a team of 1-10 employees, Atox Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Atox Bio, raised $3.3M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
1
Lead Investors
0
Total Funding Amount
$58.4M
Details
3
Atox Bio has raised a total of $58.4M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2017 | Late Stage Venture | 30.0M | ||
| 2014 | Late Stage Venture | 23.0M | ||
| 2011 | Early Stage Venture | 3.3M |
Investors
Atox Bio is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Casper Breum | - | FUNDING ROUND - Casper Breum | 30.0M |
| Lundbeckfonden Ventures | - | FUNDING ROUND - Lundbeckfonden Ventures | 30.0M |
| Atox Bio | - | FUNDING ROUND - Atox Bio | 30.0M |
| SR One | - | FUNDING ROUND - SR One | 30.0M |
Recent Activity
There is no recent news or activity for this profile.